FDA Adverse Event Injury Summary report: N

PRECISION®

MDR report key: 2101006 · Received May 24, 2011

Report

Report Number
3006630150-2011-00729
Event Type
Injury
Date Received
May 24, 2011
Date of Event
December 29, 2010
Report Date
December 29, 2010
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
PMA / PMN Number
030017
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DEVICE EVALUATION INDICATED THAT THE IPG PASSED ELECTRICAL AND PHOTOGRAPHIC IMAGING TESTS PERFORMED. THE ANALOG IC (AIC-U1) WAS DAMAGED. THE BATTERY DEPLETION RATE WITH STIMULATION OFF MEASURED 94 MVDC PER DAY, THIS EXCEEDS THE TYPICAL BATTERY DEPLETION RATE. THE AIC-U1 DAMAGE RESULTED IN THE RAPID BATTERY DEPLETION RATE OF THE IPG. THE MONOPOLAR ELECTROCAUTERY PROCEDURES ARE A KNOWN SOURCE OF HIGH-VOLTAGE TRANSIENT SIGNAL THAT CAN DAMAGE THE AIC-U1. THE BATTERY PROFILE REVEALED THAT THE AIC-U1 WAS DAMAGED PRIOR THE EXPLANT PROCEDURE. THE PATIENT HAD A LEAD REVISION PRIOR THE EXPLANT PROCEDURE BUT IT COULD NOT BE DETERMINED IF ELECTROCAUTERY WAS USED. THE BATTERY AND ITS INSULATION WERE DAMAGED BECAUSE THE FACILITY STERILIZED THE DEVICE AFTER IT WAS EXPLANTED.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT HE PATIENT WAS HAVING TO CHARGE HER IPG MORE OFTEN. A BSN REPRESENTATIVE ANALYZED THE IPG DATABASE AND CONFIRMED PREMATURE BATTERY DEPLETION. THE IPG WAS REPLACED AND THE PATIENT WAS REPORTEDLY DOING WELL FOLLOWING THE PROCEDURE.

Description of Event or Problem · 1

A REPORT WAS RECEIVED THAT HE PATIENT WAS HAVING TO CHARGE HER IPG MORE OFTEN. A BSN REPRESENTATIVE ANALYZED THE IPG DATABASE AND CONFIRMED PREMATURE BATTERY DEPLETION. THE IPG WAS REPLACED AND THE PATIENT WAS REPORTEDLY DOING WELL FOLLOWING THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PRECISION® SPINAL CORD STIMULATOR LGW BOSTON SCIENTIFIC NEUROMODULATION SC-1110-02 N/A

Patients

Seq Age Sex Outcome Treatment
1 74 YR Required Intervention